Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
14
Number of overlapping holdings
16.7%
% of WDNA's 90 holdings also in CNCR
19.4%
% of CNCR's 72 holdings also in WDNA
Overlap by Weight
Sector Drift (WDNA minus CNCR)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in WDNA |
Weight in CNCR |
Overlap | |
|---|---|---|---|---|
 |
BLUEPRINT MEDICINES CORP. | 2.6% | 2.1% | 2.1% |
|
BRISTOL-MYERS SQUIBB CO | 1.5% | 2.4% | 1.5% |
 |
BIONTECH SE SPONSORED ADR | 1.3% | 1.6% | 1.3% |
|
MERCK & CO. INC. | 1.1% | 1.5% | 1.1% |
 |
GENMAB A/S SPONSORED ADR | 1.1% | 1.5% | 1.1% |
Position Highlights (Non-Overlapping Exposures)
WDNA Overweight Relative to CNCR
|
NATERA INC | 3.7% |
|
TWIST BIOSCIENCE CORP. | 3.3% |
|
NOVOZYMES A/S-B SHARES | 2.9% |
|
ELI LILLY & CO | 2.7% |
|
VERICEL CORPORATION | 2.6% |
|
BRIDGEBIO PHARMA, INC. | 2.4% |
|
VERACYTE INC | 2.1% |
|
AGIOS PHARMACEUTICALS INC | 1.9% |
|
GILEAD SCIENCES INC | 1.9% |
|
VERTEX PHARMACEUTICALS INC | 1.8% |
WDNA Underweight Relative to CNCR
|
RECURSION PHARMACEUTICALS, INC CLASS | -3.6% |
|
INTREXON CORP | -3.2% |
|
EXELIXIS INC | -2.7% |
|
SPRINGWORKS THERAPEUTICS, INC. | -2.7% |
|
GENELUX CORP. | -2.5% |
|
COMPASS THERAPEUTICS, INC. | -2.4% |
|
2SEVENTY BIO, INC. | -2.1% |
|
REPLIMUNE GROUP, INC. | -2.0% |
|
ZYMEWORKS INC. | -2.0% |
|
GINKGO BIOWORKS HOLDINGS INC CLASS A | -2.0% |